University of Miami
Miami, FL
I am an early-stage investigator dedicated to the field of cancer radiobiology. My primary research objective is to unravel the intricate processes and mechanisms involved in the development of normal tissue toxicities caused by chemoradiotherapy. Specifically, I am focused on investigating the role of cholesterol metabolism and its potential therapeutic implications in this context. By gaining a deeper understanding of these mechanisms, my research aims to contribute to the development of novel therapeutic approaches that can effectively mitigate the toxic effects of chemoradiotherapy, enhance the efficacy of anticancer drugs, and ultimately improve the overall quality of life for cancer survivors. Currently, my research efforts are directed towards finding strategies to minimize chemoradiotherapy-induced normal tissue toxicities, optimize the effectiveness of anticancer medications, and promote better outcomes and well-being for individuals who have undergone cancer treatment.
Disclosures:
2760 - Role of ATP Binding Cassette Subfamily A Member 1 (ABCA1) in Renal Toxicity
Monday, September 30, 2024
5:00 PM – 6:00 PM ET